| P/E (FY) | — | Sales (TTM) | $16.9M |
| Earnings (TTM) | -$13.9M | ROE | — |
| Net Margin | −38.53% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | −8.16% |
| Market Cap | $49.6M | Trading Days | 716 |
| 52W High | 2.97 |
| 52W Low | 1.18 |
| % Off High | −47.47% |
| YTD | 9.86% | 1Y | −43.27% |
| Since incept. (ann.) | −34.17% |
| Ann. Volatility (1Y) | 69.45% | Ann. Volatility (3Y) | 97.84% |
| Sharpe (1Y) | −0.49 | Sharpe (3Y) | 0.04 |
| Max Drawdown (1Y) | −56.36% | Max Drawdown (3Y) | −81.89% |
| Beta (3Y, vs SPY) | 2.23 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| SRTS | Sensus Healthcare, Inc. | $48.4M | — |
| LUNG | Pulmonx Corp | $52.8M | — |
| SNWV | SANUWAVE Health, Inc. | $54.7M | 4.6 |
| DRIO | DarioHealth Corp. | $54.8M | 0.7 |
| AURX | Nuo Therapeutics, Inc. | $43.6M | — |
| XTNT | Xtant Medical Holdings, Inc. | $59.7M | 14.2 |
| PAVM | PAVmed Inc. | $39.1M | — |
| MCAG | Mountain Crest Acquisition Corp. V | $38.1M | — |
| LNSR | LENSAR, Inc. | $64.8M | — |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | $67.1M | — |
| NSPR | InspireMD, Inc. | $32.1M | — |
| Beyond Air, Inc. |
| $78.7M |
| — |
